| abstract |
The present invention relates to a deuterated diaminopyrimidine compound and a drug composition comprising this compound. Specifically, the present invention provides a pharmaceutical composition comprising a deuterated diaminopyrimidine represented by formula (I) and the compound, or a crystalline form, pharmaceutically acceptable salt, hydrate or solvate thereof. Publish. The compounds of the invention can be used for the treatment and / or prevention of protein kinase related diseases such as cell proliferative diseases, cancer, immune diseases. |